SEATTLE, Sept. 13 /PRNewswire/ -- Impulse Dynamics (U.S.A.) Inc. announced today new data supporting the company’s Optimizer System which uses Cardiac Contractility Modulation (CCM) therapy for the treatment of heart failure. These new data, based on the largest randomized study to date evaluating Impulse’s OPTIMIZER System were announced on September 13th. The release came in a late-breaking clinical trials session at the 2006 Heart Failure Society of America’s 10th Annual Scientific Meeting underway in Seattle, Washington.
